Next Article in Journal
Bioactive Isopimarane Diterpenes from the Fungus, Epicoccum sp. HS-1, Associated with Apostichopus japonicus
Previous Article in Journal
Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
Open AccessReview

Anticancer Properties of Lamellarins

Pierre Fabre Research Institute, Research & Development Center, 3 Avenue Hubert Curien, BP 13562, 31035 Toulouse cedex 1, France
Academic Editor: David J. Newman
Mar. Drugs 2015, 13(3), 1105-1123;
Received: 28 October 2014 / Revised: 24 December 2014 / Accepted: 13 February 2015 / Published: 19 February 2015
In 1985 the first lamellarins were isolated from a small oceanic sea snail. Today, more than 50 lamellarins have been inventoried and numerous derivatives synthesized and tested as antiviral or anticancer agents. The lead compound in the family is lamellarin D, characterized as a potent inhibitor of both nuclear and mitochondrial topoisomerase I but also capable of directly interfering with mitochondria to trigger cancer cell death. The pharmacology and chemistry of lamellarins are discussed here and the mechanistic portrait of lamellarin D is detailed. Lamellarins frequently serve as a starting point in the design of anticancer compounds. Extensive efforts have been devoted to create novel structures as well as to improve synthetic methods, leading to lamellarins and related pyrrole-derived marine alkaloids. View Full-Text
Keywords: lamellarins; marine natural products; cancer; topoisomerase I; mitochondria; drug synthesis lamellarins; marine natural products; cancer; topoisomerase I; mitochondria; drug synthesis
Show Figures

Figure 1

MDPI and ACS Style

Bailly, C. Anticancer Properties of Lamellarins. Mar. Drugs 2015, 13, 1105-1123.

Show more citation formats Show less citations formats

Article Access Map

Only visits after 24 November 2015 are recorded.
Back to TopTop